| Primary |
| Hypertension |
54.5% |
| Blood Cholesterol Increased |
9.1% |
| Blood Pressure |
9.1% |
| Multiple Sclerosis |
9.1% |
| Product Used For Unknown Indication |
9.1% |
| Trigeminal Neuralgia |
9.1% |
|
| Delirium |
7.7% |
| Drug Interaction |
7.7% |
| Glomerular Filtration Rate Decreased |
7.7% |
| Hypertension |
7.7% |
| Hyponatraemia |
7.7% |
| Nasopharyngitis |
7.7% |
| Pancreatitis |
7.7% |
| Paraesthesia Oral |
7.7% |
| Rash |
7.7% |
| Respiratory Distress |
7.7% |
| Rhabdomyolysis |
7.7% |
| Vision Blurred |
7.7% |
| Vomiting |
7.7% |
|
| Secondary |
| Hypertension |
51.8% |
| Product Used For Unknown Indication |
15.3% |
| Breast Cancer |
5.9% |
| Coronary Artery Disease |
3.5% |
| Blood Pressure Increased |
2.4% |
| Depression |
2.4% |
| Hypothyroidism |
2.4% |
| Urge Incontinence |
2.4% |
| Aortic Stenosis |
1.2% |
| Arthralgia |
1.2% |
| Blood Cholesterol Increased |
1.2% |
| Contraception |
1.2% |
| Dementia Alzheimer's Type |
1.2% |
| Dermatitis Contact |
1.2% |
| Diabetes Mellitus Non-insulin-dependent |
1.2% |
| Dyslipidaemia |
1.2% |
| Hyperlipidaemia |
1.2% |
| Hyperuricaemia |
1.2% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.2% |
| Psoriasis |
1.2% |
|
| Weight Increased |
16.0% |
| Hyponatraemia |
12.0% |
| Arthritis |
4.0% |
| Bradycardia |
4.0% |
| Completed Suicide |
4.0% |
| Disease Recurrence |
4.0% |
| Drug Hypersensitivity |
4.0% |
| Drug Level Below Therapeutic |
4.0% |
| Gout |
4.0% |
| Hypertriglyceridaemia |
4.0% |
| Hypotension |
4.0% |
| International Normalised Ratio Increased |
4.0% |
| Prerenal Failure |
4.0% |
| Pruritus |
4.0% |
| Pulmonary Hypoplasia |
4.0% |
| Renal Failure Acute |
4.0% |
| Syncope |
4.0% |
| Torsade De Pointes |
4.0% |
| Urticaria |
4.0% |
| Uterine Leiomyoma |
4.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
48.9% |
| Hypertension |
17.2% |
| Pain |
4.1% |
| Rheumatoid Arthritis |
4.0% |
| Diabetes Mellitus |
3.2% |
| Blood Cholesterol Increased |
1.9% |
| Blood Triglycerides Increased |
1.9% |
| Drug Use For Unknown Indication |
1.9% |
| Multiple Myeloma |
1.8% |
| Prophylaxis |
1.8% |
| Gastrooesophageal Reflux Disease |
1.6% |
| High Density Lipoprotein Decreased |
1.6% |
| Osteoporosis |
1.6% |
| Depression |
1.5% |
| Type 2 Diabetes Mellitus |
1.5% |
| Contraception |
1.4% |
| Constipation |
1.2% |
| Cardiac Failure |
1.1% |
| Low Density Lipoprotein Increased |
1.1% |
| Back Pain |
1.0% |
|
| Flushing |
16.2% |
| Feeling Hot |
7.1% |
| Deep Vein Thrombosis |
6.1% |
| Weight Decreased |
6.1% |
| Erythema |
5.1% |
| Nausea |
5.1% |
| Osteoporosis |
5.1% |
| Transient Ischaemic Attack |
5.1% |
| Vomiting |
5.1% |
| Blood Glucose Increased |
4.0% |
| Drug Ineffective |
4.0% |
| Dyspnoea |
4.0% |
| Paraesthesia |
4.0% |
| Pruritus |
4.0% |
| Tremor |
4.0% |
| Anaphylactic Shock |
3.0% |
| Blood Pressure Increased |
3.0% |
| Brain Herniation |
3.0% |
| Diarrhoea |
3.0% |
| Dizziness |
3.0% |
|
